Endocrine News Podcast

Latest Episodes:

ENP66: New Endocrine Society Journal JCEM Case Reports Jan 18, 2023

Show notes

ENP65: Type 1 Diabetes and Challenges Across the Lifespan Jan 04, 2023

Show notes

In this episode, host Aaron Lohr looks back at the Endocrine Society’s Type 1 Diabetes Fellows Conference, which occurred last year, with two conference presenters talking about developmental challenges in type 1 diabetes, including psychological and social, across the lifespan. Our guests are Linda Siminerio, PhD, professor of medicine at University of Pittsburgh and executive director of the university’s Diabetes Institute, and Jill Weissberg-Benchell, PhD, professor of psychiatry and behavioral sciences at Northwestern University. Dr. Siminerio’s presentation was titled, “Identifying and Confronting Challenging Transitions.” Dr. Weissberg-Benchell’s presentation was titled, “Developmental Perspectives in the Psychosocial Aspects of Diabetes.” Thanks to the conference’s supporters who have made this episode possible through unrestricted, educational grants: Abbott Laboratories, Dexcom, Insulet, Lilly, Medtronic, Novo Nordisk, PreventionBio, and Tandem Diabetes Care. Editor’s note: this interview was recorded in 2022. Show notes are available at https://www.endocrine.org/podcast/enp65-type-1-diabetes-and-challenges-across-the-lifespan — for more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

ENP64: More Testing Needed for Men With Hypogonadism Dec 14, 2022

Show notes

In this episode, Aaron talks with Travis Goettemoeller, MD, internal medicine resident at Cleveland Clinic, about an abstract he and a colleague presented at ENDO 2022 about the bone mineral density testing of men for hypogonadism. The abstract is titled, “Lack of Bone Mineral Density Testing in Men with Hypogonadism: A Clinical Conundrum.” Show notes are available at https://www.endocrine.org/podcast/enp64-more-testing-needed-for-men-with-hypogonadism — for more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

ENP63: Vosoritide and Children With Genetic Short Stature Nov 30, 2022

Show notes

We look at Vosoritide, a promising, potential treatment for children with genetic short stature who do not have chondrodysplasia. Host Aaron Lohr talks with Andrew Dauber, MD, division chief of endocrinology at Children’s National Hospital. Dr. Dauber and colleagues presented about Vosoritide at ENDO 2022. Their abstract is titled, “A Prospective Clinical Trial of Vosoritide in Selected Genetic Causes of Short Stature.” Show notes are available at https://www.endocrine.org/podcast/enp63-vosoritide-and-children-with-genetic-short-stature — for more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

ENP62: Parabens as an EDC and Addressing Disparities in Risk and Research Nov 16, 2022

Show notes

Endocrine-disrupting chemicals are pretty much everywhere, and all of us have some level of exposure. Today we will talk about research presented at ENDO 2022 on a group of EDCs called parabens. The title of that abstract is “Parabens Promote Pro-Tumorigenic Effects in Luminal Breast Cancer Cell Lines With Diverse Genetic Ancestry.” Host Aaron Lohr talks with one of the authors of that study, Lindsey Treviño, PhD, assistant professor at City of Hope National Medical Center. They talk not just about the effects of parabens as an EDC, but also about racial and ethnic disparities in risk and mortality, as well as research, and how Dr. Treviño and colleagues address these disparities. Show notes are available at https://www.endocrine.org/podcast/enp62-parabens-as-an-edc-and-addressing-disparities-in-risk-and-research — for more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

ENP61: Islet Cell Transplantation for Diabetes Nov 02, 2022

Show notes

In this episode, we talk about an exciting experimental treatment for patients with type 1 diabetes called islet cell transplantation. Host Aaron Lohr talks with David Baidal, MD, assistant professor of medicine at the University of Miami Miller School of Medicine. This episode is made possible through an unrestricted, educational grant from Vertex Pharmaceuticals. Show notes are available at https://www.endocrine.org/podcast/enp61-islet-cell-transplantation-for-diabetes — for more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

ENP60: CGM and Prediabetes Oct 19, 2022

Show notes

We know how helpful continuous glucose monitors are for individuals with diabetes, but might they be of benefit to individuals with prediabetes? Today host Aaron Lohr will talk with Hisham Farhan, MD, an endocrinology fellow at the University of Maryland Medical Center. Dr. Farhan and colleagues made an oral presentation at ENDO 2022 titled, “Impact of Continuous Glucose Monitoring (CGM) on Lifestyle Modifications in Individuals with Prediabetes.” Show notes are available at https://www.endocrine.org/podcast/enp60-cgm-and-prediabetes — for more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

ENP59: Fructose and Liver Disease Oct 05, 2022

Show notes

Fructose is sweeter than glucose and is often added to processed foods as a sweetener, commonly in the form of high-fructose corn syrup. Some studies suggest that fructose consumption may be associated with nonalcoholic fatty liver disease, and some new research, recently presented at ENDO, addresses this issue. Host Aaron Lohr talks with one of the authors of this research, Theodore Friedman, MD, PhD, chairman of internal medicine at Charles R. Drew University of Medicine & Science and professor of medicine at University of California, Los Angeles. Dr. Friedman and colleagues’ oral presentation at ENDO 2022 is titled, “Fructose Consumption in Nonalcoholic Fatty Liver Disease in U.S. Adult Population of NHANES 17-18” (NHANES being a national health and nutrition examination survey). For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

ENP58: Oncoendocrinology Sep 21, 2022

Show notes

Today we shine a spotlight on a fascinating area of focus within endocrinology that maybe you haven't heard much about: oncoendocrinology. What is it, and how are health providers working together to care for patients who have endocrine conditions and cancer? Host Aaron Lohr talks with Afreen I. Shariff, MD, an endocrinologist at Duke University School of Medicine with expertise in endocrine disease in cancer patients. Dr. Shariff is the founding director of the Duke Endocrine-Oncology Program and an associate director for the Cancer Treatment Toxicity Program at the Duke Center for Cancer Immunotherapy. She also chairs the oncoendocrinology special interest group with the Endocrine Society, and she is a host of the podcast “Checkpoint NOW.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

ENP57: Male Runners and Bone Health Sep 07, 2022

Show notes

We know that exercise is good for us, but for athletes who run, how might that level of running impact their bones? Host Aaron Lohr talks about new research on this topic presented at ENDO 2022 with one of the study’s presenters, Melanie Schorr Haines, MD, assistant professor of medicine at Massachusetts General Hospital. Dr. Haines and colleagues’ presentation at ENDO 2022 is titled, “Male Runners Have Impaired Tibial Cortical Bone Integrity and Strength Compared to Non-athletes.”For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected